Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL321052 | 0.80 | — | — | |
| SCHEMBL27418579 | 0.79 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL16711663 | 0.79 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL2483108 | 0.79 | CHRM2 (0.32) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL28488909 | 0.78 | CHRM2 (0.41) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL25623893 | 0.75 | CHRM2 (0.30) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL28156859 | 0.75 | — | — | |
| SCHEMBL29271885 | 0.75 | — | — | |
| SCHEMBL20171114 | 0.75 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL18537455 | 0.75 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2025-04-03 | — | — | US | claimed |
| CN-119495793-A | Non-negative electrode lithium metal battery and preparation method and application thereof | 西湖大学 | 2025-02-21 | — | — | CN | claimed |
| CN-119447413-A | Non-negative electrode lithium metal battery and preparation method and application thereof | 西湖大学 | 2025-02-14 | — | — | CN | claimed |
| EP-4471923-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2024-12-04 | — | — | EP | claimed |
| CN-116565325-A | Lithium battery electrolyte with lithium borate salt and trifluoroacetamide compound | 西湖大学 | 2023-08-08 | — | — | CN | claimed |
| WO-2023142739-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | 西湖大学 | 2023-08-03 | — | — | WO | claimed |
| CN-116365031-A | Electrolyte and lithium ion battery | 蜂巢能源科技(无锡)有限公司 | 2023-06-30 | — | — | CN | claimed |
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2025-04-03 | — | — | US | disclosed |
| CN-119495793-A | Non-negative electrode lithium metal battery and preparation method and application thereof | 西湖大学 | 2025-02-21 | — | — | CN | disclosed |
| CN-119447413-A | Non-negative electrode lithium metal battery and preparation method and application thereof | 西湖大学 | 2025-02-14 | — | — | CN | disclosed |
| WO-2025018894-A1 | BIO-RENEWABLE SURFACTANTS BASED ON FRUCTOSE AND FATTY ACID ESTERS. | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2025-01-23 | — | — | WO | disclosed |
| EP-4471923-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | Westlake University (CN) | 2024-12-04 | — | — | EP | disclosed |
| CN-119032075-A | Process for producing purified fluoroether compound-containing composition | 大金工业株式会社 | 2024-11-26 | — | — | CN | disclosed |
| US-20160176871-A1 | TGF BETA R ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY | 2016-06-23 | — | — | US | disclosed |
| US-20150362835-A1 | RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE USING THE SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20150307517-A1 | ANTIMICROBIAL AGENTS | TAXIS PHARMACEUTICALS, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150248057-A1 | RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING THE SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| EP-0583591-B1 | Process for the preparation of oxiranalcohols of high enantiomeric purity | HOECHST AG (DE) | 1996-10-09 | — | — | EP | disclosed |
| US-5478954-A | Recrystallizing mixture of two enantiomers in an organic solvent mixture comprising aliphatic and aromatic hydrocarbons, halogenated aliphatic and aromatic hydrocarbons, ethers. esters, and amides | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-12-26 | — | — | US | disclosed |
| EP-0583591-A2 | Process for the preparation of oxiranalcohols of high enantiomeric purity | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250112280-A1 | LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND | HCN2, SLC9A5, SLC9B2 | CHRM2 2290/4885CHRM4 2265/4885CHRM5 1386/4885 |
| US-20160176871-A1 | TGF BETA R ANTAGONISTS | TGFBR2, TGFBR1, TGFB1 | CHRM2 3949/4885CHRM4 4520/4885CHRM5 4115/4885 |
| US-20150307517-A1 | ANTIMICROBIAL AGENTS | CFTR, MRPL21, ARG1 | CHRM2 3256/4885CHRM4 4283/4885CHRM5 4422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.